CardiOx seeks $4 million to support launch of heart defect test

01/4/2013 |

CardiOx is looking to raise $4 million in a funding round as the company awaits regulatory clearance for its flagship product: a noninvasive test to detect a heart defect called patent foramen ovale. The Columbus, Ohio-based company will use the money to launch the assay during the first half of the year, said CEO Larry Heaton.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC